Skip to main content Help with accessibility Skip to main navigation

DEUCRAVACITINIB tablets (Sotyktu®▼) for treating moderate to severe plaque psoriasis

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 25 - Sep - 2023
Body System:
Red
DEUCRAVACITINIB tablets (Sotyktu®▼) for treating moderate to severe plaque psoriasis

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of DEUCRAVACITINIB tablets (Sotyktu ®▼), by specialists only, for treating moderate to severe plaque psoriasis in adults in accordance with NICE TA907.

NHS Cheshire and Merseyside APPROVED